E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/30/2005 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: Vyteris receives $500,000 in convertible debentures from exercise of option

By Sheri Kasprzak

New York, Dec. 29 - Vyteris Holdings (Nevada), Inc. said it has raised $500,000 in senior secured convertible debentures from an option exercised by investor Qubit Holdings LLC.

The option was part of a $10 million convertible debenture offering completed on Aug. 19, 2005.

The 8% debentures mature in 2008 and are convertible into common shares at $2.40 each.

For the exercise of the option, Qubit received warrants for 159,840 shares. The full terms of the warrants could not immediately be determined.

Based in Fair Lawn, N.J., Vyteris is a biopharmaceutical company focused on manufacturing therapeutics using iontophoresis technology.

Issuer:Vyteris Holdings (Nevada), Inc.
Issue:Senior secured convertible debentures
Amount:$500,000
Maturity:2008
Coupon:8%
Price:Par
Yield:8%
Conversion price:$2.40
Warrants:For 159,840
Investor:Qubit Holdings LLC
Settlement date:Dec. 23
Stock price:$1.40 at close Dec. 23

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.